Status:
COMPLETED
Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Mycobacterium Avium-intracellulare Infection
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
Some people who have taken azithromycin to prevent MAC (Mycobacterium avium Complex, a bacterial infection common in HIV-infected persons) have been found to carry antibiotic-resistant bacteria (germs...
Detailed Description
Streptococcus pneumoniae is a leading cause of bacteremia, pneumonia, meningitis, and otitis media in the United States. Prior to 1987, this organism was uniformly susceptible to penicillin; since the...
Eligibility Criteria
Inclusion Criteria
You may be eligible for this study if you:
- Are enrolled in CPCRA 048.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
July 1 2000
Estimated Enrollment :
326 Patients enrolled
Trial Details
Trial ID
NCT00000933
End Date
July 1 2000
Last Update
October 29 2021
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Consortium / UCSF
San Francisco, California, United States, 94110
2
Denver CPCRA / Denver Public Hlth
Denver, Colorado, United States, 80204
3
Washington Reg AIDS Prog / Dept of Infect Dis
Washington D.C., District of Columbia, United States, 20422
4
AIDS Research Consortium of Atlanta
Atlanta, Georgia, United States, 30308